法国青少年女孩接种巨细胞病毒(CMV)疫苗以预防孕妇感染的成本效果分析
研究采用马尔可夫决策树模型模拟法国39万名14岁女性队列,比较无接种、常规接种和筛查后接种三种策略至40年后。常规接种每获得一个QALY的增量成本效果比为16000欧元,具有高度成本效果;若人群血清阳性率超过62%,筛查后接种成为最有效策略。
要点
- 常规接种相比筛查后接种的ICER为16000欧元/QALY,低于法国人均GDP 30000欧元。
- 血清阳性率超过62%时,筛查后接种成为最有效策略。
核心结论
- 在法国,青少年女孩常规接种疫苗是预防孕期母体血清转化的最有效策略。
- 若人群免疫率低于62%,系统筛查并接种易感者将成为最具成本效果的策略。
研究设计与样本
- 马尔可夫决策树模型模拟一个390000名14岁法国女性虚构队列,随访至其生育期结束40年后。
- 比较三种策略:S1不接种(当前实践)、S2常规接种、S3筛查后对血清阴性者接种。
- 模型参数:未接种孕妇每周血清转化率0.035%,胎儿传播风险41%,疫苗较不接种降低母体血清转化50%。
主要发现
- S2最有效,获得35000个QALY,成本最高为211533000欧元;S1效果最差且成本最低为75423000欧元。
- S3相比S1的ICER为6000欧元/QALY(95%不确定性范围2700-13300)。
- S2相比S3的ICER为16000欧元/QALY(95%不确定性范围负ICER(S3被S2主导)至94000)。
- 敏感性分析:若血清阳性率超过62%(基础案例为20%),S3成为最有效策略。
关键数值与推荐
- ICER低于法国人均GDP 30000欧元,判定为高度成本效果。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: CMV infections are the most frequent congenital infections worldwide. AIM: Assess the cost-effectiveness of vaccination strategies of adolescent girls vs. current practice (hygiene counseling) to prevent CMV seroconversions during pregnancy in France. METHOD: A Markov decision-tree model simulated overtime the trajectory of a single fictive cohort of 390,000 adolescent women aged 14 years old, living in France. Impact of vaccination was explored until the end of their reproductive live 40 years later. STRATEGIES COMPARED: "S1: No vaccination" (current practice); "S2: Routine vaccination"; "S3: Screening and vaccination of the seronegative". MODEL PARAMETERS: Seroconversion rate without vaccination (0.035%/pregnant woman-week); fetal transmission risk (41%). Vaccine vs. no vaccination: a 50% decrease in maternal seroconversions. OUTCOMES: Quality-Adjusted Life-Years (QALYs) of the cohort-born babies; discounted costs; Incremental Cost-Effectiveness Ratio (ICER). RESULTS: S2 was the most effective strategy (with 35,000 QALYs gained) and the most expensive (€211,533,000); S1 was the least effective and least costly (€75,423,000). ICERs of strategy S3 vs. S1, and S2 vs. S3 were 6,000€/QALY gained (95% uncertainty range [2700-13,300]) and 16,000€/QALY [negative ICER (S3 dominated by S2) - 94,000] gained, respectively; highly cost-effective because ICER < 1∗France's GPD/capita = €30,000. SENSITIVITY ANALYSIS: If the seroprevalence was >62% (vs. 20% in the base case), S3 would become the most efficient strategy. CONCLUSION: In France, systematic vaccination of adolescent girls was the most efficient strategy to prevent maternal seroconversions. If the population was less than 62% immune, systematic screening and vaccination of susceptibles would become the most cost-effective approach.
引用
- N'Diaye DS, Launay O, Picone O, et al. Cost-effectiveness of vaccination against cytomegalovirus (CMV) in adolescent girls to prevent infections in pregnant women living in France. Vaccine. 2018. PMID: 29397227. doi:10.1016/j.vaccine.2018.01.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。